LATEST SCHOLARSHIP

The Fate of the Collateral Source Rule After Healthcare Reform

The passage of the Patient Protection and Affordable Care Act (PPACA) brought vast changes to the world of health insurance. Although much of the focus has been on the individual mandate provision’s constitutionality, this Comment explores a less...

Edifying Thoughts of a Patent Watcher: The Nature of DNA

In the pending case Myriad Genetics v. Association for Molecular Pathology, the U.S. Supreme Court will consider the patentability of human genes under the “product of nature” doctrine. Patentable subject matter is generally held to encompass...

Discovery From the Trenches: The Future of Brady

The so-called “due diligence” rule, which excuses prosecutors’ compliance with Brady v. Maryland if the defense could have obtained the exculpatory evidence on its own, is only a symptom of the greater problem ailing the American criminal justice...